Myocardial infarction: coronary reperfusion
Indicator
The proportion of patients with ST-segment elevation myocardial infarction (STEMI) who had coronary reperfusion therapy.
Indicator type
Network / system level indicator.
The indicator would be appropriate to understand and report on the performance of networks or systems of providers.
This document does not represent formal NICE guidance. For a full list of NICE indicators, see our menu of indicators.
To find out how to use indicators and how we develop them, see our NICE indicator process guide.
Rationale
All patients with ST-segment elevation myocardial infarction (STEMI) presenting 12 hours or less after onset of symptoms should undergo coronary reperfusion therapy. Coronary reperfusion therapy can be fibrinolysis or primary percutaneous coronary intervention.
Source guidance
Specification
Numerator: The number of patients in the denominator who had coronary reperfusion therapy.
Denominator: The number of patients with STEMI.
Calculation: Numerator divided by the denominator, multiplied by 100.
Exclusions:
-
Patients with contraindication to coronary reperfusion therapy.
-
Patients presenting too late after onset of symptoms.
-
Patients who refuse treatment.
Data source: Myocardial Ischaemia National Audit Project (MINAP) dataset.
Minimum population: The indicator would be appropriate to understand and report on the performance of networks or systems of providers.
ISBN: 978-1-4731-5562-6